HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Nutrition & Obesity Medicine
RCT
Full-fat dairy vs. low-fat dairy with energy restriction for weight and metabolic outcomes in adults with overweight/obesity
Full-Fat Dairy May Help Your Heart, Even Without Weight Loss
A 12-week RCT in 74 adults with overweight or obesity compared three daily servings of full-fat dairy to a low-fat dairy energy restriction …
Adding three daily servings of full-fat dairy improved blood pressure and diet quality in adults with overweight, offering heart benefits ev…
Apr 11, 2026
Nutrition & Obesity Medicine
Meta-analysis
Meta-analysis finds distinct neural activation patterns to food and monetary rewards in overweight/obesity
Brain scans reveal how food and money rewards differ in people with overweight or obesity
A meta-analysis of 26 fMRI studies (1065 participants) found individuals with overweight/obesity show both overlapping and distinct neural a…
Researchers analyzed brain scan data from over 1,000 people to see how brains respond to food and money rewards.
Apr 8, 2026
Diabetes & Endocrinology
RCT
Calorie restriction plus exercise reduced IL-6 and knee pain more than diet alone in knee OA
Small study finds adding exercise to calorie restriction may reduce knee pain and inflammation
A 4-week RCT in 23 overweight/obese adults with knee osteoarthritis compared calorie restriction alone to restriction plus aerobic exercise.
Adding exercise to a calorie-reduced diet lowered knee pain and a specific inflammation marker in overweight people with knee osteoarthritis…
Apr 8, 2026
Nutrition & Obesity Medicine
Meta-analysis
GLP-1RAs reduce MACE risk in Asian and White adults with diabetes or overweight
Do heart benefits from diabetes drugs work equally well across different races?
A meta-analysis of 74,703 adults with type 2 diabetes or overweight/obesity found GLP-1RAs reduced MACE risk versus placebo.
Diabetes drugs protect hearts in Asian and White adults, but the benefit for Black adults remains unclear due to small study numbers.
Apr 8, 2026
Diabetes & Endocrinology
RCT
Phase 1b trial of oral GLP-1 agonist HDM1002 shows weight reduction in Chinese adults with overweight/obesity
Can a new pill help with weight loss? Early trial shows promise
A phase 1b randomized controlled trial in Chinese adults with overweight/obesity without diabetes found greater weight reductions with oral …
A new oral weight-loss pill helped adults lose about 6 kilograms in just 28 days, showing early promise compared to a placebo.
Apr 8, 2026
Diabetes & Endocrinology
Prediabetes in youth with overweight/obesity associated with lower baseline cognition, stable over 2 years
Could prediabetes affect how young people with obesity think and learn?
A 2-year longitudinal observational study of 67 youth with overweight/obesity found those with prediabetes had lower IQ and poorer executive…
Youth with prediabetes show lower IQ and slower thinking skills compared to peers with normal blood sugar, and these cognitive differences s…
medRxiv
Apr 5, 2026
Diabetes & Endocrinology
Cohort
Horseshoe-like plantar hyperkeratosis associated with prediabetes in overweight adults
Could a specific foot skin change be a visible clue for prediabetes?
A cross-sectional cohort study of 191 adults with overweight or obesity found horseshoe-like plantar hyperkeratosis (HSLPH) was more frequen…
A horseshoe-shaped patch of thickened skin on the foot is a strong visual clue for prediabetes in adults with overweight or obesity.
Frontiers
Apr 4, 2026
Diabetes & Endocrinology
FDA Approval
FDA Approves FOUNDAYO (orforglipron) for chronic weight management in adults with obesity or overweight with comorbidities
The FDA has approved a new daily pill called FOUNDAYO to help adults manage their weight
The FDA has approved FOUNDAYO (orforglipron), an oral GLP-1 receptor agonist, for chronic weight management in adults with obesity or overwe…
FDA approves new daily pill FOUNDAYO for adults to manage weight alongside diet and exercise.
FDA
Apr 3, 2026
Diabetes & Endocrinology
Meta-analysis
Tirzepatide improves patient-reported physical function in adults with overweight or obesity
Tirzepatide may improve physical function for adults with overweight or obesity
A meta-analysis of 4,531 participants found that once-weekly tirzepatide 10 or 15 mg significantly improved physical function scores compare…
Adults with overweight or obesity taking tirzepatide reported better physical function scores on two questionnaires compared to those taking…
Apr 2, 2026
Diabetes & Endocrinology
Meta-analysis
Network meta-analysis compares exercise types for insulin resistance in youth with overweight or obesity
Which exercise works best for insulin resistance in kids with extra weight?
A network meta-analysis of 63 RCTs involving 3,286 children and adolescents with overweight or obesity compared exercise modalities.
For kids with extra weight, short bursts of intense exercise best lower insulin levels, while mixing cardio and weights works best for dropp…
Apr 2, 2026
Nutrition & Obesity Medicine
RCT
Phase 1 trial of once-weekly eloralintide shows weight reduction in obesity over 12 weeks
Can a new weekly injection help people lose weight? Early results show promise
A Phase 1 randomised controlled trial in 100 participants with obesity or overweight found that once-weekly subcutaneous eloralintide result…
A new weekly shot helped people with obesity lose between 2.6% and 11.3% of their body weight in early safety testing, though larger studies…
Apr 2, 2026
Diabetes & Endocrinology
RCT
Mediterranean lifestyle intervention reduces BMI, fat mass in preschool girls at risk of obesity
Could a Mediterranean lifestyle help preschool girls at risk of obesity? A new study suggests it might
In a 12-month RCT of 206 preschoolers at risk of obesity, a Mediterranean lifestyle intervention (diet, physical activity) significantly red…
A Mediterranean lifestyle improved body fat and BMI for preschool girls at risk of obesity, but the same healthy habits did not help boys in…
Mar 30, 2026